AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
ResMed Inc.
Video analysis: RMD
All videosNo video analysis for this stock yet. Request one from our team.
News: RMD
ResMed: A Significant Upside Despite The Perceived Risk
ResMed has de-rated from 30x to under 21x earnings despite 17% EPS growth, driven by narrative rather than fundamentals. Recurring mask and consumables revenue, now 42% of the sleep and breathing segment, is underappreciated and grew 13% last year. Two major risks—sleep apnea pill and reimbursement—are less material for RMD than feared; Philips' US return poses the most credible threat.
The IRS Lets You Send Your RMD Straight to Charity and Skip the Tax Entirely. These 3 ETFs Replace the Income You Gave Away
A Qualified Charitable Distribution can wipe your RMD off your tax return entirely, but it also kills the income you were counting on. Three ETFs can rebuild that cash flow, and they each do it a completely different way.
ResMed Inc. $RMD Shares Purchased by Hsbc Holdings PLC
Hsbc Holdings PLC grew its position in shares of ResMed Inc. (NYSE: RMD) by 13.4% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 355,518 shares of the medical equipment provider's stock after buying an additional 42,007 shares during
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ResMed Inc. - RMD
NEW YORK, Sept. 3, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ResMed Inc. ("ResMed" or the "Company") (NYSE: RMD).
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ResMed Inc. - RMD
NEW YORK, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of ResMed Inc. (“ResMed” or the “Company”) (NYSE: RMD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
Canada Pension Plan Investment Board Buys New Position in ResMed Inc. $RMD
Canada Pension Plan Investment Board bought a new stake in shares of ResMed Inc. (NYSE: RMD) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 55,511 shares of the medical equipment provider's stock, valued at approximately $10,818,000.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ResMed Inc. - RMD
NEW YORK, Aug. 27, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ResMed Inc. ("ResMed" or the "Company") (NYSE: RMD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
Resmed Announces Participation in the 24th Annual Morgan Stanley Global Healthcare Conference
SAN DIEGO, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Aaron Bloomer, chief financial officer, will attend the 24th Annual Morgan Stanley Global Healthcare Conference in New York, NY on Tuesday, September 15, 2026. Resmed's webcast presentation will begin at approximately 10:00 a.m. (Eastern Time).
Similar companies
-
Alcon Inc.
ALC
·
New York Stock Exchange
Compare
-
IQVIA Holdings Inc.
IQV
·
New York Stock Exchange
Compare
-
Humana Inc.
HUM
·
New York Stock Exchange
Compare
-
GE HealthCare Technologies Inc.
GEHC
·
NASDAQ
Compare
-
Agilent Technologies, Inc.
A
·
New York Stock Exchange
Compare
-
Mettler-Toledo International Inc.
MTD
·
New York Stock Exchange
Compare